Astria Therapeutics, Inc. (NASDAQ:ATXS) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Astria Therapeutics Quarter Three 2023 Corporate Update. At this time, all attendees are in a listen-only mode.

Related Keywords

,Andrew Komjathy ,Noah Clauser ,Jill Milne ,David Shaw Quant ,Eun Yang ,Liz Higgins ,Christopher Morabito ,Elizabeth Higgins ,Sam Slutsky ,Seema Shorin ,Andrea Matthews ,Nasdaq ,Astria Therapeutics Inc ,Amgen ,Astria Therapeutics ,Call Transcript November ,Astria Therapeutics Quarter Three ,Investor Relations ,Chief Executive Officer ,Chief Medical Officer ,Chief Commercial Officer ,Chief Business Officer ,Chief Financial ,Chief Executive ,Hereditary Angioedema ,Subject Trial ,Pivotal Phase ,Chief Financial Officer ,Hedge Funds ,Wall Street Analysts Are Crazy About ,Billionaire David Shaw ,Quant Models Love These ,